Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Prostate Cancer”

108 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 108 results

Early research (Phase 1)Study completedNCT03205176
What this trial is testing

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Who this might be right for
Malignant Solid TumorsLymphomaOvarian Cancer+3 more
AstraZeneca 49
Not applicableStudy completedNCT02920229
What this trial is testing

68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated

Who this might be right for
68Ga-PSMA HBED-PET/CTProstate Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,230
Testing effectiveness (Phase 2)Ended earlyNCT00780975
What this trial is testing

Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
PharmaMar 8
Not applicableUnknownNCT05455736
What this trial is testing

STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Observational Study

Who this might be right for
Prostate CancerRelapse
Azienda Ospedaliero-Universitaria Careggi 90
Early research (Phase 1)Study completedNCT01495663
What this trial is testing

Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned

Who this might be right for
Cancer
Cellectar Biosciences, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT01787331
What this trial is testing

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7+2 more
University of California, San Francisco 21
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT00771017
What this trial is testing

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Not applicableEnded earlyNCT01100866
What this trial is testing

Study of POMELLA™ Extract to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
Vancouver Coastal Health 1
Testing effectiveness (Phase 2)Study completedNCT00283803
What this trial is testing

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 32
Large-scale testing (Phase 3)Looking for participantsNCT04242017
What this trial is testing

Long-term Better Than Short-term ADT With Salvage RT

Who this might be right for
Prostate Cancer
Universitaire Ziekenhuizen KU Leuven 394
Early research (Phase 1)Study completedNCT05159518
What this trial is testing

PRT2527 in Participants With Advanced Solid Tumors

Who this might be right for
SarcomaCastrate Resistant Prostate CancerHormone Receptor Positive HER2 Negative Breast Cancer+2 more
Prelude Therapeutics 30
Not applicableStudy completedNCT02699424
What this trial is testing

Prospective Evaluation of 68-Ga-prostate Specific Membrane Antigen (PSMA)-Positron Emission Tomograph (PET) and Early Prostatic Specific Antigen (PSA) Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical Prostatectomy

Who this might be right for
Relapsed Prostate Cancer
Lund University Hospital 100
Early research (Phase 1)Study completedNCT00441337
What this trial is testing

MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Who this might be right for
Carcinoma, Non-Small-Cell LungColorectal CancerMalignant Melanoma+2 more
Bristol-Myers Squibb 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT04114825
What this trial is testing

Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer

Who this might be right for
Prostate Cancer Recurrent
RhoVac APS 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT03795207
What this trial is testing

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)

Who this might be right for
Node; ProstateBone MetastasesProstate Cancer Patients
Institut Cancerologie de l'Ouest 96
Testing effectiveness (Phase 2)Study completedNCT00223665
What this trial is testing

Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 102
Large-scale testing (Phase 3)Not Yet RecruitingNCT05232578
What this trial is testing

Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness

Who this might be right for
Prostate Cancer
General University Hospital, Prague 380
Large-scale testing (Phase 3)Study completedNCT01272050
What this trial is testing

Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 350
Not applicableActive Not RecruitingNCT01492751
What this trial is testing

Effectiveness of Localized Prostate Cancer Treatments

Who this might be right for
Prostate Cancer
Fundacion IMIM 500
Load More Results